-
Lupin gets FDA approval for generic Mycobutin
MUMBAI and BALTIMORE — Lupin on Wednesday announced that it received approval from the Food and Drug Administration for rifabutin capsules USP, 150 mg — a generic version of Pharmacia and Upjohn Company's Mycobutin capsules. The company's U.S. subsidiary will begin marketing the product soon.
The drug is used for the prevention of disseminated Mycobacterium avium complex disease in patients with advanced HIV infection. Mycobutin capsules had annual sales of $18.6 million in the United States, according to IMS MAT. -
APhA publishes guidebook on conducting Comprehensive Medication Reviews
WASHINGTON — To provide pharmacist a detail description of each step in the comprehensive medication review, the American Pharmacists Association has published How to Conduct a Comprehensive Medication Review: A Guidebook for Pharmacists, the association has announced.
The new guide covers such areas as: